CytoDyn (CYDY) Assets (2011 - 2026)
CytoDyn's (CYDY) quarterly Assets came in at $18.5 million in Q1 2026, down 12.71% YoY from $21.2 million in Q1 2025, and up 107.02% on a QoQ basis from $8.9 million in Q4 2025.
CytoDyn (CYDY) Assets (2011 - 2026) Analysis & Trends
CytoDyn (CYDY) has 16 years of Assets data on file, last reported at $18.5 million in Q1 2026.
- Quarterly Assets fell 12.71% year-over-year to $18.5 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $18.5 million (down 12.71% YoY) and the FY2025 annual result came in at $18.0 million, up 62.06% from the prior year.
- Assets grew to $18.5 million in Q1 2026, from $8.9 million in the prior quarter.
- In the past five years, Assets ranged from a high of $94.1 million in Q1 2022 to a low of $7.1 million in Q4 2022.
- A 5-year average of $21.2 million and a median of $14.6 million in 2023 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets plunged 93.18% — and 2024, when it jumped 169.23%.
- Tracing CYDY's Assets over 5 years: stood at $7.1 million in 2022, then jumped by 30.62% to $9.2 million in 2023, then surged by 169.23% to $24.9 million in 2024, then plunged by 64.08% to $8.9 million in 2025, then surged by 107.02% to $18.5 million in 2026.
- The last three Assets figures came in at $18.5 million (Q1 2026), $8.9 million (Q4 2025), and $13.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | CytoDyn | 258.01 Mn | 258.01 Mn | - | 18.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 18.50 Mn |
| Nov 30, 2025 | 8.94 Mn |
| Aug 31, 2025 | 13.48 Mn |
| May 31, 2025 | 18.05 Mn |
| Feb 28, 2025 | 21.19 Mn |
| Nov 30, 2024 | 24.88 Mn |
| Aug 31, 2024 | 28.02 Mn |
| May 31, 2024 | 11.14 Mn |
| Feb 29, 2024 | 10.27 Mn |
| Nov 30, 2023 | 9.24 Mn |
| Aug 31, 2023 | 12.41 Mn |
| May 31, 2023 | 11.29 Mn |
| Feb 28, 2023 | 14.64 Mn |
| Nov 30, 2022 | 7.07 Mn |
| Aug 31, 2022 | 28.39 Mn |
| May 31, 2022 | 29.19 Mn |
| Feb 28, 2022 | 94.08 Mn |
| Nov 30, 2021 | 103.70 Mn |
| Aug 31, 2021 | 104.97 Mn |
| May 31, 2021 | 132.08 Mn |